David Silberstein
Directeur/Membre du Conseil chez LANTERN PHARMA INC.
Fortune : - $ au 31/05/2024
Postes actifs de David Silberstein
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| LANTERN PHARMA INC. | Directeur/Membre du Conseil | 01/06/2018 | - |
| Independent Dir/Board Member | 01/06/2018 | - | |
BioMimetix Pharmaceutical, Inc.
 BioMimetix Pharmaceutical, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Omni Bio Pharmaceutical, Inc., BioMimetix Pharmaceutical, Inc. provides development services for biopharmaceutical products. The company is based in Greenwood Village, CO. BioMimetix Pharmaceutical was acquired by Omni Bio Pharmaceutical, Inc. on July 21, 2011 for $2 million. | Directeur des opérations | 01/01/2013 | - |
Biological Mimetics, Inc.
 Biological Mimetics, Inc. Pharmaceuticals: MajorHealth Technology Biological Mimetics, Inc. engages in the provision of pharmaceutical products. It offers deceptive imprinting, vaccines, dampening, refocusing, and therapeutic antibodies. The company was founded by Peter L. Nara in 1996 and is headquartered in Frederick, MD. | Directeur/Membre du Conseil | 01/01/2016 | - |
Historique de carrière de David Silberstein
Formation de David Silberstein
| The Trustees of Columbia University in The City of New York | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 5 |
Opérationnelle
| Director/Board Member | 2 |
| Independent Dir/Board Member | 1 |
| Chief Operating Officer | 1 |
Sectorielle
| Health Technology | 3 |
| Commercial Services | 2 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| LANTERN PHARMA INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
BioMimetix Pharmaceutical, Inc.
BioMimetix Pharmaceutical, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Omni Bio Pharmaceutical, Inc., BioMimetix Pharmaceutical, Inc. provides development services for biopharmaceutical products. The company is based in Greenwood Village, CO. BioMimetix Pharmaceutical was acquired by Omni Bio Pharmaceutical, Inc. on July 21, 2011 for $2 million. | Commercial Services |
Biological Mimetics, Inc.
Biological Mimetics, Inc. Pharmaceuticals: MajorHealth Technology Biological Mimetics, Inc. engages in the provision of pharmaceutical products. It offers deceptive imprinting, vaccines, dampening, refocusing, and therapeutic antibodies. The company was founded by Peter L. Nara in 1996 and is headquartered in Frederick, MD. | Health Technology |
- Bourse
- Insiders
- David Silberstein
- Expérience
